Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
89 hedge funds and large institutions have $75.1M invested in Applied Genetic Technologies Corporation in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
63% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 24
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
1% less funds holding
Funds holding: 90 → 89 (-1)
31% less capital invested
Capital invested by funds: $108M → $75.1M (-$33.4M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $183K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.79M |
| 2 |
Renaissance Technologies
New York
|
+$1.56M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$974K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$892K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$703K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$3.14M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$2.88M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.17M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$2.13M |
| 5 |
Millennium Management
New York
|
-$1.3M |
AGTC Hedge Fund Activity: Q1 2017 in Review
89 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2017, worth a combined $75.1M — down 31% from $108M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new AGTC positions and 9 closed out — a net gain of 5 holders — while 39 added to existing stakes and 24 trimmed.
The largest buyer was BlackRock, adding an estimated $7.79M. The largest seller was Emerald Mutual Fund Advisers Trust, exiting entirely with an estimated $3.14M sold.
- 89 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2017, down from 90 in Q4 2016.
- Funds reported $75.1M of Applied Genetic Technologies Corporation stock for Q1 2017, down 31% quarter-over-quarter.
- 14 funds opened new Applied Genetic Technologies Corporation positions in Q1 2017 and 9 closed out, a net change of +5 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q1 2017 was BlackRock, an estimated $7.79M added.
- The largest Applied Genetic Technologies Corporation seller in Q1 2017 was Emerald Mutual Fund Advisers Trust, an estimated $3.14M sold.
Based on aggregated 13F filings for Q1 2017.